Showing results (1-10 of 178) with videos related to
Sort By:
Pageof 18
Core Evidence|May 29, 2015
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillationTushar Acharya, Prakash DeedwaniaAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 16, 2019
Cardiovascular Protection with Anti-hyperglycemic AgentsPrakash Deedwania, Tushar AcharyaProgress in Cardiovascular Diseases|August 24, 2019
Cardiovascular outcome trials of the newer anti-diabetic medicationsTushar Acharya, Prakash DeedwaniaJournal of the American College of Cardiology|December 10, 2021
Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9Joshua J Joseph, Robin Ortiz, Tushar Acharya, et al.The American Journal of Cardiology|November 28, 2015
Frequent Atrial Premature Complexes and Their Association With Risk of Atrial FibrillationTushar Acharya, Steven Tringali, Manminder Bhullar, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 11, 2011
Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockersPrakash DeedwaniaJournal of the American Heart Association|October 30, 2018
The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery DiseasePrakash DeedwaniaJournal of Clinical Hypertension (Greenwich, Conn.)|November 6, 2007
Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patientsPrakash DeedwaniaInternational Journal of Cardiology|August 22, 2008
The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolismPrakash DeedwaniaDrugs|September 26, 2013
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failurePrakash DeedwaniaPageof 18